Correlation Between Merck and Genmab AS
Can any of the company-specific risk be diversified away by investing in both Merck and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Genmab AS, you can compare the effects of market volatilities on Merck and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Genmab AS.
Diversification Opportunities for Merck and Genmab AS
Very poor diversification
The 3 months correlation between Merck and Genmab is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Merck i.e., Merck and Genmab AS go up and down completely randomly.
Pair Corralation between Merck and Genmab AS
Considering the 90-day investment horizon Merck Company is expected to generate 0.66 times more return on investment than Genmab AS. However, Merck Company is 1.51 times less risky than Genmab AS. It trades about 0.01 of its potential returns per unit of risk. Genmab AS is currently generating about -0.06 per unit of risk. If you would invest 9,930 in Merck Company on August 27, 2024 and sell it today you would lose (12.00) from holding Merck Company or give up 0.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. Genmab AS
Performance |
| Timeline |
| Merck Company |
| Genmab AS |
Merck and Genmab AS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and Genmab AS
The main advantage of trading using opposite Merck and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.| Merck vs. Capricor Therapeutics | Merck vs. Soleno Therapeutics | Merck vs. Bio Path Holdings | Merck vs. Moleculin Biotech |
| Genmab AS vs. Eliem Therapeutics | Genmab AS vs. HCW Biologics | Genmab AS vs. Scpharmaceuticals | Genmab AS vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |